IGM Biosciences (IGMS) News Today → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free IGMS Stock Alerts $9.34 -0.78 (-7.71%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineIGM Biosciences Inc (IGMS) Q1 2024 Earnings: Aligns with EPS Projections Amidst Clinical ...finance.yahoo.com - May 10 at 5:02 PMAnalysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), IGM Biosciences (IGMS) and Elanco Animal Health (ELAN)markets.businessinsider.com - May 9 at 3:33 PMWedbush Keeps Their Buy Rating on IGM Biosciences (IGMS)markets.businessinsider.com - May 9 at 3:33 PMWedbush Reiterates "Outperform" Rating for IGM Biosciences (NASDAQ:IGMS)marketbeat.com - May 9 at 9:17 AMIGMS Stock Earnings: IGM Biosciences Meets EPS, Misses Revenue for Q1 2024investorplace.com - May 9 at 12:07 AMIGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Updateglobenewswire.com - May 8 at 4:10 PMIGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conferenceglobenewswire.com - May 7 at 7:00 AMIGM Biosciences (NASDAQ:IGMS) Shares Gap Down to $10.07marketbeat.com - May 6 at 6:30 PMIGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Rating of "Moderate Buy" from Analystsamericanbankingnews.com - May 4 at 5:54 AMIGM Biosciences Upgraded to Buy: What Does It Mean for the Stock?markets.businessinsider.com - May 2 at 2:11 PMIGM Biosciences (NASDAQ:IGMS) Trading Up 13.7%marketbeat.com - April 26 at 8:32 PMIGM Biosciences Insiders Placed Bullish Bets Worth US$992.2kfinance.yahoo.com - April 19 at 7:53 AMWhat 5 Analyst Ratings Have To Say About IGM Biosciencesmarkets.businessinsider.com - April 18 at 2:40 PMAnalysts’ Opinions Are Mixed on These Healthcare Stocks: IGM Biosciences (IGMS) and Argenx Se (ARGX)markets.businessinsider.com - April 18 at 10:47 AMIGM Biosciences (NASDAQ:IGMS) Receives "Neutral" Rating from HC Wainwrightmarketbeat.com - April 18 at 8:23 AMBig drugmaker's cancer rollback trickles down to another Bay Area companybizjournals.com - April 17 at 6:25 PMIGM Biosciences (NASDAQ:IGMS) Shares Down 4.9% marketbeat.com - April 17 at 1:52 PMIGM Biosciences, Inc.: IGM Biosciences Announces Refocusing of Sanofi Collaborationfinanznachrichten.de - April 17 at 1:25 PMWhy IGM Biosciences Is Rising In Pre-market?markets.businessinsider.com - April 17 at 1:25 PMIGM Biosciences Announces Refocusing of Sanofi Collaborationfinance.yahoo.com - April 17 at 8:36 AMIGM Biosciences Announces Refocusing of Sanofi Collaborationglobenewswire.com - April 17 at 8:30 AMIGM Biosciences, Inc. (NASDAQ:IGMS) Short Interest Up 9.7% in Marchmarketbeat.com - April 15 at 11:57 AMIGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forumglobenewswire.com - April 10 at 7:00 AMIGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Recommendation of "Moderate Buy" from Brokeragesmarketbeat.com - April 9 at 4:26 AMIGM Biosciences, Inc. (IGMS)finance.yahoo.com - April 8 at 8:47 AMIGM Biosciences, Inc. (NASDAQ:IGMS) Short Interest Up 5.5% in Marchmarketbeat.com - April 5 at 1:58 AMIGM Biosciences (NASDAQ:IGMS) Trading Down 3.2%marketbeat.com - April 3 at 1:57 PMIGM Biosciences (NASDAQ:IGMS) Shares Gap Up to $9.65marketbeat.com - April 1 at 11:58 AMIGM Biosciences, Inc. (NASDAQ:IGMS) Director Acquires $937,690.26 in Stockinsidertrades.com - March 29 at 8:20 AMIGM Biosciences, Inc. (NASDAQ:IGMS) Director Bros. Advisors Lp Baker Buys 97,473 Sharesmarketbeat.com - March 28 at 9:17 PMIGM Biosciences (NASDAQ:IGMS) Trading Down 6.7%marketbeat.com - March 25 at 4:23 PMAnalysts Offer Insights on Healthcare Companies: Pharvaris (PHVS), Alpine Immune Sciences (ALPN) and IGM Biosciences (IGMS)markets.businessinsider.com - March 19 at 2:10 PMMisbah Tahir Sells 2,897 Shares of IGM Biosciences, Inc. (NASDAQ:IGMS) Stockinsidertrades.com - March 17 at 6:00 AMHudson Bay Capital Management LP Purchases New Position in IGM Biosciences, Inc. (NASDAQ:IGMS)marketbeat.com - March 17 at 5:12 AMInsider Selling: IGM Biosciences, Inc. (NASDAQ:IGMS) CFO Sells 2,897 Shares of Stockmarketbeat.com - March 15 at 10:54 PMIGMS Apr 2024 22.500 callfinance.yahoo.com - March 15 at 9:42 PMIGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Rating of "Hold" from Brokeragesmarketbeat.com - March 15 at 6:42 AMIGM Biosciences (NASDAQ:IGMS) Shares Up 2.7%marketbeat.com - March 14 at 1:23 PMQ1 2024 EPS Estimates for IGM Biosciences, Inc. Increased by Analyst (NASDAQ:IGMS)marketbeat.com - March 14 at 6:40 AMIGM Biosciences (NASDAQ:IGMS) Stock Price Down 5.5%marketbeat.com - March 11 at 12:44 PMIGM Biosciences Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lagfinance.yahoo.com - March 9 at 8:32 AMIGM Biosciences, Inc.: IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - March 9 at 1:14 AMIGMS Stock Earnings: IGM Biosciences Beats EPS, Misses Revenue for Q4 2023investorplace.com - March 8 at 12:16 AMIGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updatestockhouse.com - March 7 at 7:24 PMIGM Biosciences GAAP EPS of -$1.01 beats by $0.08, revenue of $0.7M misses by $0.07Mmsn.com - March 7 at 7:24 PMIGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updateglobenewswire.com - March 7 at 4:10 PMIGM Biosciences (IGMS) Price Target Increased by 9.28% to 21.01msn.com - February 24 at 11:01 PMIGM Biosciences Stock (NASDAQ:IGMS), Short Interest Reportbenzinga.com - February 22 at 9:24 AMIGM Biosciences, Inc. (NASDAQ:IGMS) Given Consensus Rating of "Hold" by Brokeragesmarketbeat.com - February 19 at 5:24 AMWall Street Analysts Believe IGM Biosciences, Inc. (IGMS) Could Rally 35.08%: Here's is How to Tradefinance.yahoo.com - February 14 at 12:09 PM Get IGM Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IGMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Tech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. IGMS Media Mentions By Week IGMS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IGMS News Sentiment▼0.390.56▲Average Medical News Sentiment IGMS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IGMS Articles This Week▼122▲IGMS Articles Average Week Get IGM Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IGMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AVBP News AVTE News PHAT News CDMO News CALT News APLT News ATXS News STOK News GHRS News OLMA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IGMS) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmithRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHow Biden has already won 2024Porter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IGM Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
